Source: Business Wire

Press Release: Lung Therapeutics : Lung Therapeutics Receives SBIR Award for Kidney Fibrosis Research; Principal Investigator BreAnne Mackenzie Will Speak at 4th Annual IPF Summit 2020/Digital

AUSTIN, Texas--(BUSINESS WIRE)-- #CKD--Clinical-stage biopharm company Lung Therapeutics awarded SBIR grant for kidney fibrosis research. Senior scientist will present at 4th IPF Summit.

Read full article »
Lung Therapeutics's Competitors | Lung Therapeutics's News | Lung Therapeutics's Financials
Stay up-to-date with the latest news on Lung Therapeutics
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Brian Windsor's photo - CEO of Lung Therapeutics

CEO

Brian Windsor

CEO Approval Rating

90/100

Read more
Stay up-to-date with the latest news on Lung Therapeutics